BUYINS.NET: Market Maker Surveillance Report. PFE, TWX, CSCO, MDT, DEPO, QQQ, Bearishly Biased Price Friction For Thursday, September 4th 2014
(M2 PressWIRE Via Acquire Media NewsEdge) BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Thursday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Thursday there were 4751 companies with "abnormal" market making, 1909 companies with positive Friction Factors and 3133 companies with negative Friction Factors. Here is a list of the top companies with Abnormal Price Friction (bearish bias) in their stock prices. This means that there was more buying than selling in the stocks and their stock prices dropped. Pfizer Inc (NYSE:PFE), TIME WARNER INC. (NYSE:TWX), CISCO SYSTEMS INCORPORATED (NASDAQ:CSCO), Medtronic Inc (NYSE:MDT), Depomed Inc (NASDAQ:DEPO), Powershares Qqq Trust Series 1 (NASDAQ:QQQ). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
Market Maker Friction Factor is shown in the chart below:
Symbol Change Percent Buy Volume Buy %% Sell Volume Sell %% Net Volume Friction
PFE $-0.030 -0.10% 7,382,030 33.05% 6,308,770 28.24% 1,073,260 Abnormal
TWX $-0.100 -0.13% 2,417,821 36.76% 1,197,497 18.21% 1,220,324 Abnormal
CSCO $-0.110 -0.44% 10,410,925 51.83% 9,483,778 47.22% 927,147 Abnormal
MDT $-0.300 -0.47% 2,752,398 29.78% 2,044,891 22.12% 707,507 Abnormal
DEPO $-0.040 -0.26% 2,377,292 63.12% 1,339,699 35.57% 1,037,593 Abnormal
QQQ $-0.010 -0.01% 12,729,255 52.08% 10,977,230 44.91% 1,752,025 Abnormal
Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above had more buying than selling on Thursday and their stock prices dropped. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.
For example, the chart above shows PFE with 1,073,260 greater shares of buying than selling (NetVol) and the stock price was down $-0.03000. This means the Market Makers were trading the stock in a way inconsistent with normal supply and demand (Economics 101); more buying than selling should cause prices to rise.
Pfizer Inc (NYSE:PFE) - Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells medicines for people and animals worldwide. Its Primary Care segment offers human prescription pharmaceutical products primarily prescribed by primary-care physicians for Alzheimer s disease, cardiovascular, erectile dysfunction, genitourinary, major depressive disorder, pain, respiratory, and smoking cessation therapeutic and disease areas. The company's Specialty Care and Oncology segment provides human prescription pharmaceutical products for anti-infectives, endocrine disorders, hemophilia, inflammation, ophthalmology, pulmonary arterial hypertension, specialty neuroscience, and vaccines, as well as oncology and oncology-related illnesses. Its Established Products and Emerging Markets segment offers human prescription pharmaceutical products that have lost patent protection or marketing exclusivity in certain countries and/or regions, as well as that are sold in emerging markets, including Asia, Latin America, the Middle East, Eastern Europe, Africa, Turkey, and Central Europe. The company's Animal Health segment offers products and services to prevent and treat disease in livestock and companion animals, including anti-infectives, vaccines, parasiticides, medicinal feed additives, other pharmaceutical products, and other non-pharmaceutical products. Its Consumer Healthcare segment provides non-prescription products in therapeutic categories, such as dietary supplements, pain management, respiratory, and personal care. The company sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, veterinarians, livestock producers, and grocery and convenience stores. Pfizer Inc. has a strategic collaboration with CytomX Therapeutics, Inc. to develop and commercialize Multiple Probody drug conjugates in oncology. The company was founded in 1849 and is headquartered in New York, New York..
TIME WARNER INC. (NYSE:TWX) - Time Warner Inc. operates as a media and entertainment company in the United States and internationally. The company operates in three segments: Networks, Film and TV Entertainment, and Publishing. The Networks segment consists of Turner Broadcasting System, Inc. and Home Box Office, Inc. It operates domestic and international television networks; provides premium pay and basic tier television programming services; and operates various digital media properties, which primarily consist of brand-aligned Websites. This segment also operates the HBO and Cinemax domestic multi-channel premium pay television services. It provides programming to cable system operators, satellite service distributors, telephone companies, and other distributors; sells advertising; engages in the sale of DVDs and Blu-ray discs; and domestic and international licensing of original programming to television networks. The Film and TV Entertainment segment consists of businesses managed by Warner Bros. Entertainment Inc. that principally produce and distribute feature films, television shows, and videogames. It distributes home video products; and licenses rights to its feature films, television programming, and characters. The Publishing segment comprises Time Inc. s magazine publishing and related Websites, as well as book publishing and marketing businesses. This segment publishes magazines on style and entertainment, lifestyle, news, and sports. The company s brands include TNT, TBS, CNN, HBO, Cinemax, Warner Bros., New Line Cinema, People, Sports Illustrated, and Time. Time Warner Inc. was founded in 1985 and is headquartered in New York, New York..
CISCO SYSTEMS INCORPORATED (NASDAQ:CSCO) - Cisco Systems, Inc. designs, manufactures, and sells Internet protocol (IP) and other products related to the communications and information technology industry worldwide. It provides switching products, including fixed-configuration and modular switches, and storage products that provide connectivity to end users, workstations, IP phones, access points, and servers, as well as function as aggregators on local-area networks and wide-area networks; and routers that interconnects public and private wireline and mobile networks for mobile, data, voice, and video applications. The company also offers set-top boxes, cable modem termination systems, hybrid fiber coaxial access network products, quadrature amplitude modulation products, and cable modems; and video software and solutions. In addition, it provides collaboration products comprising IP phones, call center and messaging products, unified communications infrastructure products, and Web-based collaborative offerings, as well as telepresence systems; and security products such as firewall, intrusion prevention, remote access, virtual private networks, unified clients, network admission control, Web gateways, and email gateways, which deliver identity, network, and content security solutions for mobile, collaborative, and cloud-enabled businesses. Further, the company offers wireless products consisting of wireless access points and network managed services, as well as standalone, switch-converged, and cloud managed solutions; and data center products, which include blade and rack servers, fabric interconnects, software, and server access virtualization solutions; and other products, such as emerging technologies and other networking products. Additionally, it provides technical support services and advanced services. The company was founded in 1984 and is headquartered in San Jose, California..
Medtronic Inc (NYSE:MDT) - Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. The company operates in two segments, Cardiac and Vascular Group, and Restorative Therapies Group. The Cardiac and Vascular Group s products include pacemakers; implantable defibrillators; leads and delivery systems; ablation products; electrophysiology catheters; products for the treatment of atrial fibrillation; information systems for the management of patients with cardiac rhythm disease management (CRDM) devices; coronary and peripheral stents and related delivery systems; therapies for uncontrolled hypertension; endovascular stent graft systems; heart valve replacement technologies; cardiac tissue ablation systems; and open heart and coronary bypass grafting surgical products. The Restorative Therapies Group offers products for various areas of the spine; bone graft substitutes; biologic products; trauma, implantable neurostimulation therapies, and drug delivery devices for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder (OCD), overactive bladder, urinary retention, and fecal incontinence and gastroparesis; external insulin pumps; subcutaneous CGM systems; products to treat conditions of the ear, nose, and throat; and devices that incorporate advanced energy technology. It also manufactures and sells image-guided surgery and intra-operative imaging systems; and provides Web-based therapy management software solutions. The company serves hospitals, physicians, clinicians, and patients in approximately 140 countries. Medtronic, Inc. was founded in 1949 and is headquartered in Minneapolis, Minnesota..
Depomed Inc (NASDAQ:DEPO) - Depomed, Inc., a specialty pharmaceutical company, focuses on developing products for pain and other conditions, and diseases of the central nervous system in the United States. The company primarily offers Gralise (gabapentin), an once-daily product for the management of postherpetic neuralgia; Zipsor (diclofenac potassium) liquid filled capsule, a non-steroidal anti-inflammatory drug for the treatment of mild to moderate acute pain in adults; and Glumetza, a metformin hydrochloride extended release tablets for use in adults with type 2 diabetes. It is also involved in the clinical development of two product candidates, comprising Serada, which completed Phase III clinical trials for the treatment of menopausal hot flashes; and DM-1992 that completed a Phase II trial for Parkinson's disease. The company sells its Gralise products to wholesalers and retail pharmacies. Depomed, Inc. has license and collaboration agreements with Santarus, Inc.; Covidien, Ltd.; Boehringer Ingelheim International GMBH; Ironwood Pharmaceuticals, Inc.; Merck & Co., Inc.; Janssen Pharmaceutica N.V.; Janssen Pharmaceuticals, Inc.; Abbott Products Inc.; Patheon Puerto Rico, Inc.; Valeant Pharmaceuticals International, Inc.; and PharmaNova, Inc. The company was founded in 1995 and is headquartered in Newark, California..
Powershares Qqq Trust Series 1 (NASDAQ:QQQ) - .
BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO
INVESTMENTS & TRADING
SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.
www.buyins.netCallSend SMSAdd to SkypeYou'll need Skype CreditFree via Skype
(c) 2014 M2 COMMUNICATIONS
[ InfoTech Spotlight's Homepage ]